Transcription of Rx only MITOMYCIN FOR INJECTION USP, 5 …
{{id}} {{{paragraph}}}
Version 1 NEW ZEALAND DATA SHEET 1. PRODUCT NAME MITOMYCIN , Powder f or INJECTION , 5 mg/vial 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains MITOMYCIN 5 mg. For full list of excipients, see section 3. PHARMACEUTICAL FORM Powder for solution for INJECTION . Blue-violet cake or powder. 4. CLINICAL PARTICULARS Therapeutic indications MITOMYCIN for INJECTION is not recommended as single-agent, primary therapy. It has been shown to be useful in the therapy of disseminated adenocarcinoma of the stomach or pancreas in proven combinations with other approved chemotherapeutic agents and as palliative treatment when other modalities have failed.
Bone marrow suppression, notably thrombocytopenia and leukopenia, which may contribute to overwhelming infections in an already compromised patient, is the m ost common and severe of
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}